Tranexamic acid for post-partum haemorrhage in the WOMAN trial - Authors' reply

Affiliations

¹ Clinical Trials Unit, Department of Population Health, London School of Hygiene & Tropical Medicine, London WC1E 7HT, UK.
² Clinical Trials Unit, Department of Population Health, London School of Hygiene & Tropical Medicine, London WC1E 7HT, UK. Electronic address: haleema.shakur@lshtm.ac.uk.

Comment

Ian Roberts et al. Lancet. 2017.

. 2017 Sep 30;390(10102):1584.

doi: 10.1016/S0140-6736(17)31942-6. Epub 2017 Sep 28.

¹ Clinical Trials Unit, Department of Population Health, London School of Hygiene & Tropical Medicine, London WC1E 7HT, UK.
² Clinical Trials Unit, Department of Population Health, London School of Hygiene & Tropical Medicine, London WC1E 7HT, UK. Electronic address: haleema.shakur@lshtm.ac.uk.

No abstract available

Comment on

Tranexamic acid for post-partum haemorrhage in the WOMAN trial.
Letson HL, Dobson GP. Letson HL, et al. Lancet. 2017 Sep 30;390(10102):1581-1582. doi: 10.1016/S0140-6736(17)31947-5. Epub 2017 Sep 28. Lancet. 2017. PMID: 28980953 No abstract available.
Tranexamic acid for post-partum haemorrhage in the WOMAN trial.
Dennis AT, Griffiths JD. Dennis AT, et al. Lancet. 2017 Sep 30;390(10102):1582. doi: 10.1016/S0140-6736(17)31946-3. Epub 2017 Sep 28. Lancet. 2017. PMID: 28980954 No abstract available.
Tranexamic acid for post-partum haemorrhage in the WOMAN trial.
Maeda Y, Yamamoto K, Tanimoto T, Kami M, Yoshioka S. Maeda Y, et al. Lancet. 2017 Sep 30;390(10102):1583-1584. doi: 10.1016/S0140-6736(17)31949-9. Epub 2017 Sep 28. Lancet. 2017. PMID: 28980956 No abstract available.